Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB01037_DB01393_nanopub.RA5HdhNth4JV5GJ75yD2XEEocLyg3ooN60YTI3zArXCAw#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB01037_DB01393 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01037_DB01393 label "DDI between Selegiline and Bezafibrate - MAO Inhibitors may enhance the adverse/toxic effect of Bezafibrate. Avoid concomitant use of bezafibrate with monoamine oxidase inhibitors (MAOIs) like selegiline. [drugbank_resource:DB01037_DB01393]" assertion.
- drugbank_resource:DB01037_DB01393 identifier "drugbank_resource:DB01037_DB01393" assertion.
- drugbank_resource:DB01037_DB01393 title "DDI between Selegiline and Bezafibrate - MAO Inhibitors may enhance the adverse/toxic effect of Bezafibrate. Avoid concomitant use of bezafibrate with monoamine oxidase inhibitors (MAOIs) like selegiline." assertion.
- drugbank:DB01037 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01037_DB01393 assertion.
- drugbank:DB01393 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01037_DB01393 assertion.